13F 申報指南13F 觀念全攻略
什麼是 SEC Form 13F 申報？美股機構大戶持股全攻略
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制，學會如何追蹤頂級對沖基金與機構法人持倉動向。
AlphaSMO 權威研究指南閱讀專題
CIK: 0001595725
申報總市值
US$20.5億
US$20.5億
96 檔
19.3%
Rock Springs Capital Management LP 在 Q1 2025 季度的美股部位總計估值為 US$20.5億，分散於 96 個持倉標的之中，反映其市場參與廣度與投資規模。
數據顯示 Rock Springs Capital Management LP 於 Q1 2025 季度持續回收資金，對 24 個既有部位進行裁減並清倉 105 個標的，組合整體流動性比重有所上升。
從部位權重觀察，前 5 大標的（包含 ARGX, LLY, 2655787D）累計市值佔比達 19.3%，是驅動 Rock Springs Capital Management LP 該季度整體投資組合績效表現的核心支柱。
| # | 代號 | 標的名稱 | 資產子類別 | 佔比 | 佔比變動 | 持倉量變化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ARGX | Argenx Se - Adr | 股票-醫療保健 | 5.95% | -1.85% | -23.45% | |
| 2 | LLY | Eli Lilly & Co | 股票-醫療保健 | 5.36% | +0.43% | -21.45% | |
| 3 | 2655787D | Blueprint Medicines CORP | 股票-其他 | 5.10% | — | -8.14% | |
| 4 | MDGL | Madrigal Pharmaceuticals Inc | 股票-醫療保健 | 3.16% | -0.69% | -37.15% | |
| 5 | UNH | Unitedhealth Group Inc | 股票-醫療保健 | 3.01% | +0.44% | -42.90% | |
| 6 | TVTX | Travere Therapeutics Inc | 股票-其他 | 3.00% | +3.45% | -41.27% | |
| 7 | ISRG | Intuitive Surgical Inc | 股票-醫療保健 | 2.89% | -0.75% | -52.78% | |
| 8 | RARE | Ultragenyx Pharmaceutical In | 股票-其他 | 2.89% | +0.08% | -19.85% | |
| 9 | PEN | Penumbra Inc | 股票-醫療保健 | 2.62% | -0.55% | -28.75% | |
| 10 | RVMD | Revolution Medicines Inc | 股票-醫療保健 | 2.59% | +3.17% | +5.64% | |
| 11 | RYTM | Rhythm Pharmaceuticals Inc | 股票-其他 | 2.53% | +0.21% | -28.26% | |
| 12 | MIRM | Mirum Pharmaceuticals Inc | 股票-其他 | 2.45% | +0.14% | -35.32% | |
| 13 | ✓ | Merus N V | 股票-其他 | 2.36% | — | +9.88% | |
| 14 | INSM | Insmed Inc | 股票-醫療保健 | 2.25% | -1.15% | -6.20% | |
| 15 | ALNY | Alnylam Pharmaceuticals Inc | 股票-醫療保健 | 2.21% | -0.46% | -44.09% | |
| 16 | ASND | Ascendis Pharma A/S | 股票-其他 | 1.93% | -2.62% | EXIT | |
| 17 | ZLAB | Zai Lab Ltd-adr | 股票-其他 | 1.87% | -0.14% | -30.70% | |
| 18 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 1.79% | -0.61% | -25.58% | |
| 19 | NBIX | Neurocrine Biosciences Inc | 股票-醫療保健 | 1.77% | +0.02% | -61.28% | |
| 20 | NUVL | Nuvalent Inc-a | 股票-其他 | 1.73% | — | -0.57% | |
| 21 | AGL | agilon health, inc. | 股票-其他 | 1.72% | — | -6.88% | |
| 22 | PHR | Phreesia Inc | 股票-其他 | 1.68% | +0.05% | -43.71% | |
| 23 | BSX | Boston Scientific CORP | 股票-醫療保健 | 1.60% | -0.81% | -39.78% | |
| 24 | AKRO | Akero Therapeutics Inc | 股票-其他 | 1.56% | — | -28.92% | |
| 25 | DXCM | Dexcom Inc | 股票-醫療保健 | 1.55% | -0.19% | +12.65% | |
| 26 | IRTC | Irhythm Holdings Inc | 股票-醫療保健 | 1.52% | -0.25% | -36.03% | |
| 27 | EVH | Evolent Health Inc - A | 股票-其他 | 1.46% | +0.30% | +30.86% | |
| 28 | SRRK | Scholar Rock Holding CORP | 股票-其他 | 1.40% | -0.22% | +6.24% | |
| 29 | KYMR | Kymera Therapeutics Inc | 股票-其他 | 1.24% | +0.10% | -23.18% | |
| 30 | EXK | Exact Sciences CORP | 股票-原物料 | 1.19% | — | +6.67% | |
| 31 | ACHC | Acadia Healthcare Co Inc | 股票-其他 | 1.18% | -0.10% | EXIT | |
| 32 | GPCR | Structure Therapeutics Inc | 股票-其他 | 1.12% | -0.14% | +4.81% | |
| 33 | SMMT | Summit Therapeutics Inc | 股票-其他 | 1.10% | -0.28% | -5.60% | |
| 34 | EW | Edwards Lifesciences CORP | 股票-醫療保健 | 1.06% | -0.14% | EXIT | |
| 35 | TARS | Tarsus Pharmaceuticals Inc | 股票-其他 | 1.04% | -0.08% | +219.58% | |
| 36 | THC | Tenet Healthcare CORP | 股票-醫療保健 | 1.00% | -0.25% | +0.62% | |
| 37 | LEGN | Legend Biotech Corp-adr | 股票-其他 | 1.00% | +0.01% | +0.16% | |
| 38 | IMVT | Immunovant Inc | 股票-其他 | 0.95% | — | +7.34% | |
| 39 | AZTA | Azenta Inc | 股票-其他 | 0.94% | -0.21% | — | |
| 40 | INSP | Inspire Medical Systems Inc | 股票-醫療保健 | 0.90% | +0.13% | -23.65% | |
| 41 | AM6 | Amicus Therapeutics Inc | 股票-其他 | 0.89% | -0.02% | EXIT | |
| 42 | WRBY | Warby Parker Inc-class A | 股票-其他 | 0.87% | — | -9.24% | |
| 43 | MREO | Mereo Biopharma Group Pl-adr | 股票-其他 | 0.86% | — | -30.37% | |
| 44 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 0.84% | +0.05% | -33.51% | |
| 45 | OSCR | Oscar Health Inc - Class A | 股票-醫療保健 | 0.79% | — | — | |
| 46 | WST | West Pharmaceutical Services | 股票-醫療保健 | 0.77% | — | -64.30% | |
| 47 | VERA | Vera Therapeutics Inc | 股票-其他 | 0.72% | -0.29% | +6.75% | |
| 48 | DHR | Danaher CORP | 股票-醫療保健 | 0.69% | +0.02% | — | |
| 49 | NAMS | NewAmsterdam Pharma Company N.V. | 股票-其他 | 0.63% | -0.15% | -30.15% | |
| 50 | SRPT | Sarepta Therapeutics Inc | 股票-醫療保健 | 0.58% | — | -48.20% |
| # | 代號 | 標的名稱 | 佔比變動 | 持倉量變化 | 異動類型 |
|---|---|---|---|---|---|
| 1 | ARGX | Argenx Se - Adr | +4.1% | -23.45% | 減碼 |
| 2 | 2655787D | Blueprint Medicines CORP | +3.7% | -8.14% | 加碼 |
| 3 | MDGL | Madrigal Pharmaceuticals Inc | +2.7% | -37.15% | 減碼 |
| 4 | TVTX | Travere Therapeutics Inc | +2.6% | -41.27% | 加碼 |
| 5 | RYTM | Rhythm Pharmaceuticals Inc | +2.3% | -28.26% | 加碼 |
| 6 | RARE | Ultragenyx Pharmaceutical In | +2% | -19.85% | 加碼 |
| 7 | MIRM | Mirum Pharmaceuticals Inc | +1.9% | -35.32% | 減碼 |
| 8 | PEN | Penumbra Inc | +1.8% | -28.75% | 加碼 |
| 9 | XENE | Xenon Pharmaceuticals Inc | +1.6% | -25.58% | 加碼 |
| 10 | ASND | Ascendis Pharma A/S | +1.3% | -29.18% | 減碼 |
| 11 | AKRO | Akero Therapeutics Inc | +1.3% | -28.92% | 加碼 |
| 12 | ALNY | Alnylam Pharmaceuticals Inc | +1.2% | -44.09% | 減碼 |
| 13 | DXCM | Dexcom Inc | +1.2% | +12.65% | 加碼 |
| 14 | UNH | Unitedhealth Group Inc | +1.1% | -42.90% | 減碼 |
| 15 | IRTC | Irhythm Holdings Inc | +0.9% | -36.03% | 減碼 |
| 16 | BSX | Boston Scientific CORP | +0.9% | -39.78% | 減碼 |
| 17 | EVH | Evolent Health Inc - A | +0.8% | +30.86% | 加碼 |
| 18 | LEGN | Legend Biotech Corp-adr | +0.8% | +0.16% | 加碼 |
| 19 | ISRG | Intuitive Surgical Inc | +0.7% | -52.78% | 減碼 |
| 20 | AM6 | Amicus Therapeutics Inc | +0.7% | -26.55% | 加碼 |
| 21 | KYMR | Kymera Therapeutics Inc | +0.6% | -23.18% | 加碼 |
| 22 | MREO | Mereo Biopharma Group Pl-adr | +0.6% | -30.37% | 加碼 |
| 23 | WST | West Pharmaceutical Services | +0.6% | -64.30% | 加碼 |
| 24 | PHR | Phreesia Inc | +0.5% | -43.71% | 加碼 |
| 25 | ACHC | Acadia Healthcare Co Inc | +0.3% | +16.73% | 減碼 |
| 26 | SRPT | Sarepta Therapeutics Inc | +0.1% | -48.20% | 減碼 |
| 27 | GOSS 5 06-01-27債券 | Gossamer Bio Inc | +0.1% | — | 減碼 |
| 28 | FOCL | Edap Tms SA -adr | 0% | -20.22% | 加碼 |
| 29 | NUVB-WS | Nuvation Bio Inc -cw27 | 0% | — | 不變 |
| 30 | ✓ | Inozyme Pharma Inc | -0.1% | -10.79% | 加碼 |
| 31 | APLSUSD | Apellis Pharmaceuticals Inc | -0.1% | — | 減碼 |
| 32 | ADAPY | Adaptimmune Therapeutics-adr | -0.1% | — | 加碼 |
| 33 | ✓ | Compugen LTD | -0.1% | — | 減碼 |
| 34 | EW | Edwards Lifesciences CORP | -0.1% | -53.21% | 減碼 |
| 35 | MGNX | Macrogenics Inc | -0.2% | +8.69% | 加碼 |
| 36 | NBIX | Neurocrine Biosciences Inc | -0.2% | -61.28% | 減碼 |
| 37 | EXK | Exact Sciences CORP | -0.2% | +6.67% | 減碼 |
| 38 | APLT | Applied Therapeutics Inc | -0.2% | +8.23% | 加碼 |
| 39 | CGEM | Cullinan Therapeutics Inc | -0.3% | -13.14% | 減碼 |
| 40 | SPRU | Spruce Power Holding Corporation | -0.3% | — | 加碼 |
| 41 | LUNG | Pulmonx CORP | -0.3% | -34.77% | 減碼 |
| 42 | ARDX | Ardelyx Inc | -0.3% | +9.66% | 減碼 |
| 43 | PRTA | Prothena Corporation plc | -0.6% | -23.58% | 減碼 |
| 44 | ✓ | Mersana Therapeutics Inc | -0.7% | +11.16% | 加碼 |
| 45 | ACRS | Aclaris Therapeutics Inc | -0.9% | -18.66% | 加碼 |
| 46 | NVROEUR | Nevro CORP | -1.5% | -51.43% | 加碼 |
| 47 | NVAX | Novavax Inc | -1.7% | — | 加碼 |
| 48 | ZLAB | Zai Lab Ltd-adr | -1.7% | -30.70% | 減碼 |
| 49 | AGIO | Agios Pharmaceuticals Inc | -2.2% | -27.36% | 減碼 |
| 50 | AGL | agilon health, inc. | -3.9% | -6.88% | 減碼 |
根據 SEC 官方 Form 13F 申報備案，Rock Springs Capital Management LP 在 Q1 2025 季度的美股持倉總市值約為 US$20.5億，共申報了 96 個公開持股部位。
在 Q1 2025 季度，Rock Springs Capital Management LP 按市值排列的前三大核心持股分別為：ARGX (6.0%)、LLY (5.4%)、2655787D (5.1%)。其中最大持股部位 ARGX 佔據整體投資組合約 6.0% 的權重。
精選 AlphaSMO 大戶持股與內部人交易深度分析，提升投資決策勝率
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制，學會如何追蹤頂級對沖基金與機構法人持倉動向。
本季最大新建倉標的
LLY
市值: US$9374.1萬
本季最大獲利了結 / 清倉標的
HUM
前期市值: US$1.3億
在 Q1 2025 季度中，Rock Springs Capital Management LP 共進行了 199 項持倉異動，包含新建倉 45 個部位、加碼 25 個部位、減碼 24 個部位以及清倉 105 個部位。 其中最大新建倉標的為 LLY。 本季清倉部位包含 HUM。
本頁面所有持股數據均直接同步自美國證券交易委員會（SEC）EDGAR 官方系統之 13F-HR / 13F-HR/A 季度申報文件。AlphaSMO 透過機器解析 CUSIP 與個股對照，提供 100% 精準對齊的歷史時序數據集，並支援 Schema.org 結構化資料格式。
解析公司高管、董事與 10% 大股東之 Form 4 內部人交易申報，掌握高管自家股票買賣第一手訊號。
深入剖析 5% 股益申報門檻、13D 與 13G 之差異，以及最新 SEC 申報時程規範，洞察機構法人的激進投資動向。